In Vivo Chemical Screening for Modulators of Hematopoiesis and Hematological Diseases
In vivo chemical screening is a broadly applicable approach not only for dissecting genetic pathways governing hematopoiesis and hematological diseases, but also for finding critical components in those pathways that may be pharmacologically modulated. Both high-throughput chemical screening and fac...
Saved in:
| Main Authors: | Yiyun Zhang, J.-R. Joanna Yeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2012/851674 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC
by: Ugo Testa, et al.
Published: (2022-08-01) -
The genetics of human hematopoiesis and its disruption in disease
by: Erik L Bao, et al.
Published: (2019-07-01) -
The link between ten-eleven translocation-2 (Tet2) related clonal hematopoiesis and sequential onset of two hematologic malignancies
by: Jin Huang, et al.
Published: (2025-01-01) -
Clonal hematopoiesis of indeterminate potential and risk of autoimmune thyroid disease
by: Xue Zhang, et al.
Published: (2025-04-01) -
Extramedullary Hematopoiesis in Gastric Mucosa
by: Matilda Djolai, et al.
Published: (2025-05-01)